References
- EsteJACihlarTCurrent status and challenges of antiretroviral research and therapyAntiviral Res2010851253320018390
- DeeksSGAutranBBerkhoutBTowards an HIV cure: a global scientific strategyNat Rev Immunol201212860761422814509
- DaveyRTJrBhatNYoderCHIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionProc Natl Acad Sci U S A19999626151091511410611346
- DahabiehMSBattivelliEVerdinEUnderstanding HIV latency: the road to an HIV cureAnnu Rev Med20156640742125587657
- MaldarelliFWuXSuLHIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cellsScience2014345619317918324968937
- ShanLDengKShroffNSStimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivationImmunity201236349150122406268
- DengKPerteaMRongvauxABroad CTL response is required to clear latent HIV-1 due to dominance of escape mutationsNature2015517753438138525561180
- BurkeBPBoydMPImpeyHCCR5 as a natural and modulated target for inhibition of HIVViruses201461546824381033
- LiuRPaxtonWAChoeSHomozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infectionCell19968633673778756719
- PaxtonWAMartinSRTseDRelative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposureNat Med1996244124178597950
- HütterGNowakDMossnerMLong-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantationN Engl J Med2009360769269819213682
- MartinsonJJChapmanNHReesDCLiuYTCleggJBGlobal distribution of the CCR5 gene 32-basepair deletionNat Genet19971611001039140404
- Ruiz-FerrerMBarrosoNAntinoloGAguilar-ReinaJAnalysis of CCR5-Delta 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fluorescence resonance energy transfer technologiesJ Viral Hepat200411431932315230854
- GonzalezGParkSChenDArmitageSShpallEBehringerRIdentification and frequency of CCR5Delta32/Delta32 HIV-resistant cord blood units from Houston area hospitalsHIV Med201112848148621375684
- SmithARWagnerJEAlternative haematopoietic stem cell sources for transplantation: place of umbilical cord bloodBr J Haematol2009147224626119796274
- DuarteRFSalgadoMSánchez-OrtegaICCR5 ∆32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case reportLancet HIV Epub5192015
- PetzLDRedeiIBrysonYHematopoietic cell transplantation with cord blood for cure of HIV infectionsBiol Blood Marrow Transplant201319339339723089564
- KwonMKuballJHEllerbroekPSingle cord blood transplantation combined with an HLA mismatched third party donor for high-risk hematological patients with HIV infectionBlood20131222134013401
- HütterGMore on shift of HIV tropism in stem-cell transplantation with CCR5 delta32/delta32 mutationN Engl J Med2014371252437243825517721
- KordelasLVerheyenJBeelenDWShift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutationN Engl J Med2014371988088225162903
- GragertLEapenMWilliamsEHLA match likelihoods for hematopoietic stem-cell grafts in the US registryN Engl J Med201437133934825054717
- LiuHRichESGodleyLReduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissionsBlood2011118246438644521976674
- LiuHvan BesienKAlternative donor transplantation–”mixing and matching”: the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?Curr Hematol Malig Rep20151011725667129
- Van BesienKLiuHJainNUmbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applicationsBiol Blood Marrow Transplant201319568269123142329
- KwonMBautistaGBalsalobrePHaplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disordersBiol Blood Marrow Transplant201420122015202225255162
- KwonMBalsalobrePSerranoDSingle cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disordersBiol Blood Marrow Transplant201319114314922960386
- AmadoRGMitsuyasuRTSymondsGA phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozymeHum Gene Ther199910132255227010498256
- MitsuyasuRTMeriganTCCarrAPhase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cellsNat Med200915328529219219022
- RossiJJRibozyme therapy for HIV infectionAdv Drug Deliv Rev2000441717811035199
- LiuDDoneganJNuovoGMitraDLaurenceJStable human immunodeficiency virus type 1 (HIV-1) resistance in transformed CD4+ monocytic cells treated with multitargeting HIV-1 antisense sequences incorporated into U1 snRNAJ Virol1997715407940859094686
- KohnDBBauerGRiceCRA clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected childrenBlood199994136837110381536
- Hacein-Bey-AbinaSGarrigueAWangGPInsertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1J Clin Invest200811893132314218688285
- DiGiustoDLKrishnanALiLRNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaSci Transl Med201023636ra43
- LedgerSHoweAMurrayJSymondsGLentiviral vector mediated gene therapies provide stable protection against HIV infection: the use of short-hairpin RNA to CCR5 and membrane anchored C peptide entry inhibitorsMol Ther201422S271S271
- BarclaySLYangYZhangSSafety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cellsStem Cells201533387087925524029
- CentlivreMLegrandNKlamerSPreclinical in vivo evaluation of the safety of a multi-shRNA-based gene therapy against HIV-1Mol Ther Nucleic Acids2013e2e12024002730
- CaseSSPriceMAJordanCTStable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectorsProc Natl Acad Sci U S A19999662988299310077624
- ChengQDongLZhangFShort communication: efficiently inhibiting HIV-1 replication by a prototype foamy virus vector expressing novel H1 promoter-driven short hairpin RNAsAIDS Res Hum Retroviruses201531218318825531134
- OlszkoMETrobridgeGDFoamy virus vectors for HIV gene therapyViruses20135102585260024153061
- KiemHPWuRASunGvon LaerDRossiJJTrobridgeGDFoamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivoGene Ther2010171374919741733
- TamhaneMAkkinaRStable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistanceAIDS Res Ther200851618667075
- WolsteinOBoydMMillingtonMPreclinical safety and efficacy of an anti–HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitorMol Ther Methods Clin Dev201411126015947
- YounanPMPetersonCWPolacinoPLentivirus-mediated gene transfer in hematopoietic stem cells is impaired in SHIV-infected, ART-treated nonhuman primatesMol Ther201523594395125648264
- YounanPKowalskiJKiemHPGenetic modification of hematopoietic stem cells as a therapy for HIV/AIDSViruses20135122946296224287598
- KimEKimSKimDHChoiBSChoiIYKimJSPrecision genome engineering with programmable DNA-nicking enzymesGenome Res20122271327133322522391
- HoltNWangJKimKHuman hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivoNat Biotechnol20102883984720601939
- TebasPSteinDBinder-SchollGAntiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIVBlood201312191524153323264589
- MaierDABrennanALJiangSEfficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5Hum Gene Ther201324324525823360514
- LiLKrymskayaLWangJGenomic editing of the HIV-1 core ceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleasesMol Ther20132161259126923587921
- YeLWangJBeyerAISeamless modification of wild-type induced pluripotent stem cells to the natural CCR5Delta32 mutation confers resistance to HIV infectionProc Natl Acad Sci U S A2014111269591959624927590
- MussolinoCAlzubiJFineEJTALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicityNucleic Acids Res201442106762677324792154
- MussolinoCMorbitzerRLutgeFDannemannNLahayeTCathomenTA novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicityNucleic Acids Res201139219283929321813459
- WangWYeCLiuJZhangDKimataJTZhouPCCR5 Gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infectionPLoS One2014912e11598725541967
- MandalPKFerreiraLMCollinsREfficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9Cell Stem Cell201415564365225517468
- ChoSWKimSKimJMKimJSTargeted genome engineering in human cells with the Cas9 RNA-guided endonucleaseNat Biotechnol201331323023223360966
- TebasPSteinDTangWWGene editing of CCR5 in autologous CD4 T cells of persons infected with HIVN Engl J Med20143701090191024597865
- JainNLiuHArtzASImmune reconstitution after combined haploidentical and umbilical cord blood transplantLeuk Lymphoma20135461242124923088744
- DiGiustoDLStanRKrishnanALiHRossiJJZaiaJADevelopment of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practiceViruses20135112898291924284880